Table 5.
Effects | MBM | Phy | AB | WG g | FCR | FI g | Livability % |
---|---|---|---|---|---|---|---|
Treatment | |||||||
1 | − | 500 | − | 2,762a | 1.559 | 4,306 | 85 |
2 | − | 1,500 | − | 2,451b | 1.588 | 3,894 | 85 |
3 | − | 500 | + | 2,744a | 1.550 | 4,254 | 96 |
4 | − | 1,500 | + | 2,713a | 1.527 | 4,142 | 88 |
5 | + | 500 | − | 2,769a | 1.517 | 4,200 | 76 |
6 | + | 1,500 | − | 2,186c | 1.657 | 3,619 | 80 |
7 | + | 500 | + | 2,665a,b | 1.555 | 4,138 | 92 |
8 | + | 1,500 | + | 2,816a | 1.512 | 4,260 | 89 |
2-way interactions | |||||||
Phy*AB | |||||||
500 | − | 2,766 | 1.538b | 4,253a | 80 | ||
500 | + | 2,704 | 1.553a,b | 4,196a | 94 | ||
1,500 | − | 2,319 | 1.623a | 3,757b | 83 | ||
1,500 | + | 2,765 | 1.519b | 4,201a | 89 | ||
Main effects | |||||||
AB | − | 2,542 | 1.580 | 4,005 | 81b | ||
+ | 2,734 | 1.536 | 4,198 | 91b | |||
SEM | 33.6 | 0.012 | 46.4 | 1.65 | |||
P > f | |||||||
MBM | 0.122 | 0.837 | 0.215 | 0.227 | |||
Phy | <0.001 | 0.233 | 0.002 | 0.626 | |||
AB | <0.001 | 0.042 | 0.014 | 0.003 | |||
MBM × Phy | 0.552 | 0.285 | 0.827 | 0.466 | |||
MBM × AB | 0.066 | 0.660 | 0.208 | 0.332 | |||
Phy × AB | <0.001 | 0.008 | 0.002 | 0.227 | |||
MBM × Phy × AB | 0.004 | 0.129 | 0.187 | 1.000 |
a,b,cmeans in the same column within a main effect, 2-way interaction or treatment means with different superscripts are different (P < 0.05).
AB = Salinomycin 60 ppm in S, G, F; Zn bacitracin 100 ppm in S, G and 50 ppm in F.
Phy = Phytase (Quantum Blue 5G).
2-way or 3-way interaction separated by Tukey.
Abbreviations: AB, antibiotics; FCR, feed conversion ratio; FI, feed intake; MBM, meat and bone meal; WG, weight gain.